Clinical Trial Update: MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MDRT in prostate cancer within the STAMPEDE METANOVA study; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• MDRT

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Prostate Cancer, Malignant Neoplasm of Prostate | Phase 2 | Status: RECRUITING